Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality

A novel virus named 2019 novel coronavirus (2019-nCoV/SARS-CoV-2) causes symptoms that are classified as coronavirus disease (COVID-19). Respiratory conditions are extensively described among more serious cases of COVID-19, and the onset of acute respiratory distress syndrome (ARDS) is one of the ha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical hypotheses 2020-07, Vol.140, p.109760-109760, Article 109760
Hauptverfasser:	Geier, Mark R., Geier, David A.
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Acetazolamide - therapeutic use Antiviral Agents - therapeutic use Betacoronavirus Capillaries - drug effects Coronavirus Infections - drug therapy Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 EPO Erythrocyte Transfusion Hematinics - therapeutic use Humans Hyperbaric Oxygenation Oxygen - blood Pandemics Pneumonia, Viral - mortality Pneumonia, Viral - therapy Pulmonary Respiratory Distress Syndrome - diagnosis Respiratory Distress Syndrome - virology SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!